Diabetes and eye care at the IAPB 10th General Assembly
Diabetic macular oedema (which affects around 6.8% of the diabetic population), has started to emerge as a major cause of vision loss, particularly with the increasing prevalence of type 2 diabetes.
There is also a shift in management in diabetic retinopathy (DR), with increasing recognition of new intra-ocular therapies. However, there continues to be significant challenges from a public health perspective as many of these therapies are expensive and require significant resources.
Furthermore, many patients with DR are unaware of their condition, and many countries do not have well established screening programmes. What can we do?
The IAPB 10th General Assembly will have two courses dedicated to Diabetic Retinopathy:
Course 16: Diabetic Retinopathy (Clinical)
Moderator: Tien Wong, Singapore Eye Research Institute
Course 21: Diabetic Retinopathy (Health Systems issues)
Moderator: Silvio Mariotti, World Health Organization